R J Kosgei1, P M Ndavi2, J O Ong'ech2, J M Abuya3, A M Siika3, K Wools-Kaloustian4, H Mabeya3, T Fojo5, A Mwangi3, T Reid6, M E Edginton7, E J Carter8. 1. The United States Agency for International Development-Academic Model Providing Access to Healthcare Partnership, Eldoret, Kenya ; University of Nairobi School of Medicine, Nairobi, Kenya. 2. University of Nairobi School of Medicine, Nairobi, Kenya ; Kenyatta National Hospital, Nairobi, Kenya. 3. The United States Agency for International Development-Academic Model Providing Access to Healthcare Partnership, Eldoret, Kenya ; Moi University School of Medicine, Eldoret, Kenya. 4. The United States Agency for International Development-Academic Model Providing Access to Healthcare Partnership, Eldoret, Kenya ; Moi University School of Medicine, Eldoret, Kenya ; Indiana University School of Medicine, Indianapolis, Indiana, USA. 5. Washington University School of Medicine, St Louis, Missouri, USA. 6. Operational Research Unit, Médecins Sans Frontières-Operational Centre Brussels, Luxembourg. 7. International Union Against Tuberculosis and Lung Disease, Paris, France. 8. The United States Agency for International Development-Academic Model Providing Access to Healthcare Partnership, Eldoret, Kenya ; Moi University School of Medicine, Eldoret, Kenya ; Warren Alpert School of Medicine at Brown University, Providence, Rhode Island, USA.
Abstract
OBJECTIVE: To determine the diagnostic usefulness of tuberculosis (TB) symptom screening to detect active pulmonary TB among human immunodeficiency virus (HIV) infected pregnant women in two PMTCT (prevention of mother-to-child transmission) clinics in western Kenya that are supported by the United States Agency for International Development-Academic Model Providing Access to Healthcare partnership. DESIGN: Cross-sectional study. Participants were interviewed for TB symptoms with a standardized questionnaire (cough >2 weeks, fever, night sweats, weight loss or failure to gain weight). Those with cough submitted sputum specimens for smear microscopy for acid-fast bacilli and mycobacterial culture. Women at >14 weeks gestation underwent shielded chest radiography (CXR). RESULTS: Of 187 HIV-infected women, 38 (20%) were symptom screen-positive. Of these, 21 had a cough for >2 weeks, but all had negative sputum smears and mycobacterial cultures. CXRs were performed in 26 symptomatic women: three were suggestive of TB (1 miliary, 1 infiltrates and 1 cavitary). Of 149 women with a negative symptom screen, 100 had a CXR and seven had a CXR suggestive of TB (1 cavitary, 2 miliary and 4 infiltrates). CONCLUSION: This study did not support the utility of isolated symptom screening in identification of TB disease in our PMTCT setting. CXR was useful in identification of TB suspects in both symptomatic and asymptomatic women.
OBJECTIVE: To determine the diagnostic usefulness of tuberculosis (TB) symptom screening to detect active pulmonary TB among human immunodeficiency virus (HIV) infected pregnant women in two PMTCT (prevention of mother-to-child transmission) clinics in western Kenya that are supported by the United States Agency for International Development-Academic Model Providing Access to Healthcare partnership. DESIGN: Cross-sectional study. Participants were interviewed for TB symptoms with a standardized questionnaire (cough >2 weeks, fever, night sweats, weight loss or failure to gain weight). Those with cough submitted sputum specimens for smear microscopy for acid-fast bacilli and mycobacterial culture. Women at >14 weeks gestation underwent shielded chest radiography (CXR). RESULTS: Of 187 HIV-infectedwomen, 38 (20%) were symptom screen-positive. Of these, 21 had a cough for >2 weeks, but all had negative sputum smears and mycobacterial cultures. CXRs were performed in 26 symptomatic women: three were suggestive of TB (1 miliary, 1 infiltrates and 1 cavitary). Of 149 women with a negative symptom screen, 100 had a CXR and seven had a CXR suggestive of TB (1 cavitary, 2 miliary and 4 infiltrates). CONCLUSION: This study did not support the utility of isolated symptom screening in identification of TB disease in our PMTCT setting. CXR was useful in identification of TB suspects in both symptomatic and asymptomatic women.
Authors: Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke Journal: Lancet Date: 2007-10-20 Impact factor: 79.321
Authors: Paula B N Kali; Glenda E Gray; Avy Violari; Richard E Chaisson; James A McIntyre; Neil A Martinson Journal: J Acquir Immune Defic Syndr Date: 2006-07 Impact factor: 3.731
Authors: Kevin P Cain; Kimberly D McCarthy; Charles M Heilig; Patama Monkongdee; Theerawit Tasaneeyapan; Nong Kanara; Michael E Kimerling; Phalkun Chheng; Sopheak Thai; Borann Sar; Praphan Phanuphak; Nipat Teeratakulpisarn; Nittaya Phanuphak; Huy Dung Nguyen; Thi Quy Hoang; Hung Thai Le; Jay K Varma Journal: N Engl J Med Date: 2010-02-25 Impact factor: 91.245
Authors: Elizabeth L Corbett; Abbas Zezai; Yin Bun Cheung; Tsitsi Bandason; Ethel Dauya; Shungu S Munyati; Anthony E Butterworth; Simba Rusikaniko; Gavin J Churchyard; Stanley Mungofa; Richard J Hayes; Peter R Mason Journal: Bull World Health Organ Date: 2010-01 Impact factor: 9.408
Authors: Robert M Einterz; Sylvester Kimaiyo; Haroun N K Mengech; Barasa O Khwa-Otsyula; Fabian Esamai; Fran Quigley; Joseph J Mamlin Journal: Acad Med Date: 2007-08 Impact factor: 6.893
Authors: Thomas S Inui; Winston M Nyandiko; Sylvester N Kimaiyo; Richard M Frankel; Tadeo Muriuki; Joseph J Mamlin; Robert M Einterz; John E Sidle Journal: J Gen Intern Med Date: 2007-10-31 Impact factor: 5.128
Authors: R J Kosgei; D Szkwarko; S Callens; P Gichangi; M Temmerman; A-B Kihara; J J Sitienei; E J Cheserem; P M Ndavi; A J Reid; E J Carter Journal: Public Health Action Date: 2013-12-21
Authors: L H Chaisson; F Naufal; P Delgado-Barroso; H S Alvarez-Manzo; K O Robsky; C R Miller; J E Golub; A E Shapiro Journal: Int J Tuberc Lung Dis Date: 2021-06-01 Impact factor: 3.427